ESR1 and cancer: These models can design the transitions between endocrine therapy sensitive and resistant states in breast cancer (49), the switch between estrogen receptor and growth factor signaling (50), and model in the interactions between ERα and UPR signaling (37), highlighting the usefulness of integrating mathematical modeling into cancer research.